MediciNova Inc MNOV:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:00 PM EST
5.59UNCH (UNCH)
Volume
1,156
Close
5.59quote price arrow down-0.11 (-1.93%)
Volume
79,758
52 week range
2.79 - 13.25

...

Loading . . .

KEY STATS

  • Open5.64
  • Day High5.77
  • Day Low5.52
  • Prev Close5.70
  • 52 Week High13.25
  • 52 Week High Date07/27/20
  • 52 Week Low2.79
  • 52 Week Low Date03/12/20
  • Market Cap272.12M
  • Shares Out48.68M
  • 10 Day Average Volume0.12M
  • Dividend-
  • Dividend Yield-
  • Beta1.49
  • 1 Year % Change29.85

RATIOS/PROFITABILITY

  • EPS (TTM)-0.31
  • P/E (TTM)-17.92
  • Fwd P/E (NTM)-9.32
  • EBITDA (MRQ)-14.157M
  • ROE (MRQ)-18.95%
  • Revenue (MRQ)0.00
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date04/21/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest MediciNova Inc News

There is no recent news for this security.

Latest MNOV News From Our Partners

QUOTE FINDER

Profile

MORE
Medicinova, Inc. is a biopharmaceutical company. The company is focused on developing small molecule therapeutics for the treatment of serious diseases with unmet medical needs. The Company is developing activities on MN-166 (ibudilast) for neurological disorders, such as progressive multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and substance dependence and addiction...
Jeffrey Himawan Ph.D.
Chairman
Yuichi Iwaki M.D. Ph.D.
President
Edward Stepanow
Chief Financial Officer
Geoffrey O'brien J.D.
Vice President
Address
4275 Executive Sq Ste 300
La Jolla, CA
92037-8408
United States